Mentor Capital was first drawn to look for acquisitions, and funding opportunities in the cannabis industry because it stimulates appetite and reduces nausea in cancer patients giving them extra strength to handle their other treatments.
Additionally, early research indicates that cannabis may both promote apoptosis, the orderly cell death of aberrant cancer cells, and inhibit metastasis. Even more evident is the immediate calming effect of medical marijuana in the treatment of persons afflicted with MS, seizures or Parkinson’s disease. Glaucoma patients also find the reduction of intraocular pressure when using medical marijuana. Importantly, chronic pain may be mitigated by cannabis use without the more addictive and troublesome side effects from the opiate family.
It is important to note that, in simplified terms, there are two basic active components of medical marijuana: CBD and THC. THC is the better known psycho-active component. CBD, on the other hand, is not psychoactive, yet carries many of the medical benefits.